Arbutus Biopharma Corporation Stock Performance
as on August 6, 2026 at 2:15 pm IST
Day's Low
Day's High
$4.46$4.69
3.46%
Downside
1.52%
Upside

52 Week's Low
52 Week's High
$3.31$5.38
28.46%
Downside
16.45%
Upside

Arbutus Biopharma Corporation share price movements today
- Previous Close
- $4.42
- Open
- $4.54
- Volume
- 1.4M
- Day's Low - High
- $4.46 - $4.69
- 52 Week Low - High
- $3.31 - $5.38
Arbutus Biopharma Corporation Historical Returns
- 1 Month Return
- -7.04 %
- 3 Month Return
- + 4.52 %
- 1 Year Return
- + 33.14 %
- 3 Year Return
- + 115.89 %
- 5 Year Return
- + 53.49 %
Arbutus Biopharma Corporation Stock Fundamentals & Key Indicators
Check Arbutus Biopharma Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$873.1M
EPS (TTM)
1.03
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
5.26
Industry PE ratio
-6.052631578947368
PEG Ratio
0EBITDA
155.1M
Revenue (TTM)
191.4M
Profit Margin
83.95%
Return On Equity TTM
94.73%
Arbutus Biopharma Corporation Stock Valuation
Track how Arbutus Biopharma Corporation P/E has moved over time to understand its valuation trends.
Arbutus Biopharma Corporation in the last 5 years
Lowest (-18.45x)
December 31, 2025
Industry (-6.05x)
August 6, 2026
Today (5.26x)
August 6, 2026
Highest (4.12x)
June 30, 2026
Today’s Price to Earnings Ratio: 5.26x
Arbutus Biopharma Corporation vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Arbutus Biopharma Corporation with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $873.1M | 53.49% | 5.26 | 83.95% | NA | |
| BUY | $41.1B | 605.15% | NA | 0.00% | NA | |
| BUY | $121.3B | 141.61% | 27.93 | 35.00% | NA | |
| BUY | $78.3B | 25.82% | 18.8 | 27.87% | 0.48% |
Stock Returns calculator for Arbutus Biopharma Corporation Stock including INR - Dollar returns
The Arbutus Biopharma Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Arbutus Biopharma Corporation investment value today
Current value as on today
₹1,44,314
Returns
₹44,314
(+44.31%)
Returns from Arbutus Biopharma Corporation Stock
₹33,141 (+33.14%)
Dollar Impact
₹11,173 (+11.17%)
Analyst Recommendation on Arbutus Biopharma Corporation Stock
Based on 11 analysts
81.82%
Buy
18.18%
Hold
0.00%
Sell
Based on 11 analysts, 81.82% of analysts recommend a 'BUY' rating for Arbutus Biopharma Corporation. Average target price of $5.49
Arbutus Biopharma Corporation Share Price Target
Get share price movements and forecasts by analysts on Arbutus Biopharma Corporation.
What analysts predicted
15.85%UPSIDE
Target Price
$5.49
Current Price
$4.62
Analyzed by
11 Analysts
Target
$5.49
Arbutus Biopharma Corporation target price $5.49, a slight upside of 15.85% compared to current price of $4.62. According to 11 analysts rating.
Indian Investors' Interest in Arbutus Biopharma Corporation Stock
Search interest for Arbutus Biopharma Corporation Stock has increased by 18% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:18% versus previous 30 day period
Arbutus Biopharma Corporation Quarterly Profit & Loss
All numbers in Millions USD
Arbutus Biopharma Corporation Annual Profit & Loss
All numbers in Millions USD
Arbutus Biopharma Corporation Quarterly Cash Flow
All numbers in Millions USD
Arbutus Biopharma Corporation Annual Cash Flow
All numbers in Millions USD
Arbutus Biopharma Corporation News & Key Events

Today's Timeline - 16 July
Thu, 05:00 PM
-Arbutus and Genevant filed lawsuits against Pfizer and BioNTech to enforce LNP technology patents, receiving $178M from Moderna settlement.
Insights on Arbutus Biopharma Corporation
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise

In the last 3 years, ABUS stock has moved up by 115.9%
POSITIVE IMPACTRevenue Rich

Revenue is up for the last 3 quarters, 529.0K → 179.12M (in $), with an average increase of 74.5% per quarter
POSITIVE IMPACTProfit Spike

Netprofit is up for the last 3 quarters, -7.74M → 169.69M (in $), with an average increase of 104.2% per quarter
NO EFFECTAgainst Peers

In the last 3 years, Revolution Medicines, Inc. Common Stock has given 532.2% return, outperforming this stock by 416.3%
NO EFFECTAgainst Peers

In the last 1 year, Revolution Medicines, Inc. Common Stock has given 438.0% return, outperforming this stock by 404.9%
About Arbutus Biopharma Corporation
| Organisation | Arbutus Biopharma Corporation |
| Headquarters | 701 Veterans Circle, Warminster, PA, United States, 18974 |
| Industry | Biotechnology |
| CEO | Ms. Lindsay Androski J.D., M.B.A. |
| E-voting on shares | Click here to vote |
Key Management of Arbutus Biopharma Corporation
Name | Title |
|---|---|
Mr. R. Hector Mackay-Dunn B.A., J.D., L.L.B., Q.C. | Corporate Secretary |
Ms. Lindsay Androski J.D., M.B.A. | President, CEO & Chairman |
Mr. Tuan Nguyen | Chief Financial Officer |
Mr. Andrew J. Sung | General Counsel |
FAQs
What is Arbutus Biopharma Corporation share price today?
Arbutus Biopharma Corporation share price today is $4.62 as on at the close of the market. Arbutus Biopharma Corporation share today touched a day high of $4.69 and a low of $4.46.
What is the 52 week high and 52 week low for Arbutus Biopharma Corporation share?
Arbutus Biopharma Corporation share touched a 52 week high of $5.38 on and a 52 week low of $3.31 on . Arbutus Biopharma Corporation stock price today i.e. is closed at $4.62,which is 14.13% down from its 52 week high and 39.79% up from its 52 week low.
What is Arbutus Biopharma Corporation's market capitalisation today?
Arbutus Biopharma Corporation market capitalisation is $0.00T as on .
How to invest in Arbutus Biopharma Corporation Stock (ABUS) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Arbutus Biopharma Corporation on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Arbutus Biopharma Corporation Shares that will get you 0.3247 shares as per Arbutus Biopharma Corporation share price of $4.62 per share as on August 6, 2026 at 8:45 am IST.
What is the minimum amount required to buy Arbutus Biopharma Corporation Stock (ABUS) from India?
Indian investors can start investing in Arbutus Biopharma Corporation (ABUS) shares with as little as ₹95.2 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.00 in Arbutus Biopharma Corporation stock (as per the Rupee-Dollar exchange rate as on ).
Based on Arbutus Biopharma Corporation share’s latest price of $4.62 as on August 6, 2026 at 8:45 am IST, you will get 2.1645 shares of Arbutus Biopharma Corporation. Learn more about
fractional shares .
What are the returns that Arbutus Biopharma Corporation has given to Indian investors in the last 5 years?
Arbutus Biopharma Corporation stock has given 53.49% share price returns and 28.66% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?